Vertex Pharmaceuticals Inc / Ma (VRTX) Insider Ownership

Historic Insider Ownership Trends

Data spanning the past 90 days through February 10, 2026 reveals that Vertex Pharmaceuticals's three principal insider shareholders consist of Ceo & President Reshma Kewalramani (154.82K shares), Evp Chief Patient & Ext Af Off Amit Sachdev (71.00K shares), Evp And Coo Stuart A Arbuckle (63.37K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Reshma Kewalramani Ceo & President 154,825 26 Jan, 2026
Amit Sachdev Evp Chief Patient & Ext Af Off 70,998 26 Jan, 2026
Stuart A Arbuckle Evp And Coo 63,368 02 Jul, 2025
Ourania Tatsis Evp And Chief Reg. & Quality Off. 54,042 26 Jan, 2026
Charles F Jr Wagner Evp And Co & Fo 51,325 26 Jan, 2026
Bruce I Sachs 45,000 07 Aug, 2025
Carmen Bozic Evp And Cmo 44,002 26 Jan, 2026
David Altshuler Evp And Chief Scientific Officer 34,477 26 Jan, 2026
Jeffrey M Leiden Executive Chairman 33,039 26 Jan, 2026
Bastiano Sanna Evp And Cell & Genetic Therapies 32,038 09 May, 2023
Edward Morrow Iii Atkinson Evp And Chief Technical Ops. Off. 24,669 26 Jan, 2026
Jonathan Biller Evp And Chief Legal Officer 24,374 26 Jan, 2026
Duncan Mckechnie Evp And Chief Commercial Officer 22,938 26 Jan, 2026
Kristen Ambrose Svp & Chief Accounting Officer 12,095 26 Jan, 2026
Joy Liu Svp And General Counsel 9,605 17 Aug, 2022
Alan M Garber 6,872 05 May, 2025
Terrence C Kearney 6,536 14 Aug, 2023
Lloyd Carney 6,315 20 Nov, 2025
Sangeeta N. Bhatia 4,565 29 Aug, 2025
Suketu Upadhyay 2,354 05 May, 2025
Diana Mckenzie 2,231 05 May, 2025
Nancy Thornberry 2,035 05 May, 2025
Yuchun Lee 1,875 31 Jan, 2023
Jennifer Schneider 1,718 05 May, 2025
Michel Lagarde 1,132 10 Oct, 2023
Margaret G Mcglynn 178 03 May, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
22 Jan, 2026 Charles F Jr Wagner Common Stock A 9,440 $0.00 47,165 D A
22 Jan, 2026 Charles F Jr Wagner Common Stock A 4,160 $0.00 51,325 D A
22 Jan, 2026 Jeffrey M Leiden Common Stock A 9,012 $0.00 33,039 D A
22 Jan, 2026 Amit Sachdev Common Stock A 3,883 $0.00 70,998 D A
22 Jan, 2026 Amit Sachdev Common Stock A 7,866 $0.00 67,115 D A
22 Jan, 2026 David Altshuler Common Stock A 7,866 $0.00 31,149 D A
22 Jan, 2026 David Altshuler Common Stock A 3,328 $0.00 34,477 D A
22 Jan, 2026 Reshma Kewalramani Common Stock A 11,885 $0.00 154,825 D A
22 Jan, 2026 Reshma Kewalramani Common Stock A 26,972 $0.00 142,940 D A
22 Jan, 2026 Jonathan Biller Common Stock A 6,294 $0.00 21,600 D A
22 Jan, 2026 Jonathan Biller Common Stock A 2,774 $0.00 24,374 D A
22 Jan, 2026 Ourania Tatsis Common Stock A 7,866 $0.00 50,159 D A
22 Jan, 2026 Ourania Tatsis Common Stock A 3,883 $0.00 54,042 D A
22 Jan, 2026 Carmen Bozic Common Stock A 3,467 $0.00 44,002 D A
22 Jan, 2026 Carmen Bozic Common Stock A 7,866 $0.00 40,535 D A
22 Jan, 2026 Kristen Ambrose Common Stock A 2,950 $0.00 10,795 D A
22 Jan, 2026 Kristen Ambrose Common Stock A 1,300 $0.00 12,095 D A
22 Jan, 2026 Edward Morrow Iii Atkinson Common Stock A 3,934 $0.00 20,786 D A
22 Jan, 2026 Edward Morrow Iii Atkinson Common Stock A 3,883 $0.00 24,669 D A
22 Jan, 2026 Duncan Mckechnie Common Stock A 2,080 $0.00 22,938 D A